Global Pruritus Drug Market By Types (Chronic Kidney Disease associated Pruritus, Chronic Liver Disease associated Pruritus, Atopic Dermatitis Associated Pruritus and Others), Drugs (Corticosteroids, Antihistamines, Counterirritants and Others), Route of Administration (Injectable, Topical, Oral and Others), End Users (Hospitals, Homecare, Specialty Clinics and Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retailers and Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights of Pruritus Drug Market
Data Bridge Market Research analyses that the pruritus drug will exhibit a CAGR of around 5.10% for the forecast period of 2021-2028. Rising government policies and initiatives to offer a fund to many research institute and pharmaceuticals companies to introduce novel drugs and therapies, increasing prevalence of pruritus cases worldwide, and increased expenditure for the development of healthcare infrastructure are the major factors attributable to the growth of pruritus drug market.
Pruritus is a primary skin disorder that results in an unpleasant sensation that provokes the desire to itch or scratch. In other words, pruritus is a dermatological disorder that leads to severe and vigorous itching. The intensity of itching ranges from mild itchiness to insistent.
Increase special designation from the regulatory authorities is a major factor fostering the growth of the pruritus drug market. Rising expenditure on the development of healthcare infrastructure and rising prevalence of prevalence of atopic dermatitis, allergic contact dermatitis, and urticaria is also fostering the growth of the pruritus drug market. The high demand for over-the-counter topical corticosteroids will create lucrative pruritus drug market growth opportunities.
However, non-favorable reimbursement scenario in the developing and underdeveloped economies and high costs associated with the treatment will pose a major challenge to the pruritus drug market growth. Lack of awareness in the under developing and developing economies will further challenge the pruritus drug market growth rate. Patent expiration of branded drugs and introduction of generic version will further derail the pruritus drug market growth rate.
This pruritus drug market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on pruritus drug market, contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Pruritus Drug Market Scope and Market Size
The pruritus drug market is segmented on the basis of types, drugs, route of administration, end users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of types, the pruritus drug market is segmented into chronic kidney disease associated pruritus, chronic liver disease associated pruritus, atopic dermatitis associated pruritus and others.
- On the basis of drugs, the pruritus drug market is segmented into corticosteroids, antihistamines, counterirritants, and others.
- On the basis of route of administration, the pruritus drug market is segmented into injectable, topical, oral, and others.
- On the basis of end users, the pruritus drug market is segmented into hospitals, home care settings, specialty clinics, and others.
- On the basis of distribution channel, the pruritus drug market is segmented into hospital pharmacy, online pharmacies, retailers, and others.
Pruritus Drug Market Country Level Analysis
The pruritus drug market is analysed and market size insights and trends are provided by country, types, drugs, route of administration, end users and distribution channel as referenced above.
The countries covered in the pruritus drug market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina, and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
North America dominates the market owing to the prevalence of advanced healthcare infrastructure and rising prevalence of hematologic diseases. Asia-Pacific is projected to score highest growth rate and exhibit the highest CAGR for the forecast period. This is because of the rising expenditure to develop healthcare infrastructure, increasing prevalence of allergic contact dermatitis and urticaria, and raising awareness about the treatment options.
The country section of the pruritus drug market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Pruritus drug market also provides you with detailed market analysis for patient analysis, prognosis, and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Pruritus Drug Market Share Analysis
The pruritus drug market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to pruritus drug market.
The major players covered in the pruritus drug market report are AbbVie Inc., Allergan, Merck & Co., Inc., Amgen Inc., Pfizer Inc., Cara Therapeutics., Enteris BioPharma, NeRRe Therapeutics., Menlo Therapeutics, XBiotech Inc., Ipsen Pharma, Eledon Pharmaceuticals, Inc., Amorepacific, RDD Pharma, Ltd, Novartis AG, Astrazeneca, Sanofi, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Takeda Pharmaceutical Company Limited. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-